Sangamo Therapeutics, Inc.SGMONASDAQ
Loading
Cash generated from core business operations
Percentile
P27
Within normal range
vs 5Y Ago
-0.4x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-76.16M | -13.4% |
| 2024 | $-67.14M | +70.1% |
| 2023 | $-224.84M | -0.5% |
| 2022 | $-223.63M | +4.1% |
| 2021 | $-233.25M | -237.3% |
| 2020 | $169.88M | +217.6% |
| 2019 | $-144.40M | -488.7% |
| 2018 | $37.15M | +232.3% |
| 2017 | $11.18M | +117.0% |
| 2016 | $-65.88M | - |